These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 10777152)

  • 1. Large-scale ex vivo expansion of primary T lymphocytes in late-stage AIDS patients.
    Shimizu N; Sekine T; Itoh K; Nakamura T; Iwamoto A; Satoh Y; Yamamoto K
    AIDS Res Hum Retroviruses; 2000 Apr; 16(6):611-2. PubMed ID: 10777152
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of culture medium on the expansion of T cells for immunotherapy.
    Sato K; Kondo M; Sakuta K; Hosoi A; Noji S; Sugiura M; Yoshida Y; Kakimi K
    Cytotherapy; 2009; 11(7):936-46. PubMed ID: 19903105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of artificial antigen-presenting cells with preclustered anti-CD28/-CD3/-LFA-1 monoclonal antibodies on the induction of ex vivo expansion of functional human antitumor T cells.
    Zappasodi R; Di Nicola M; Carlo-Stella C; Mortarini R; Molla A; Vegetti C; Albani S; Anichini A; Gianni AM
    Haematologica; 2008 Oct; 93(10):1523-34. PubMed ID: 18728033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD3-CD28 costimulation as a means to avoiding T cell preactivation in bispecific monoclonal antibody-based treatment of ovarian carcinoma.
    Mazzoni A; Mezzanzanica D; Jung G; Wolf H; Colnaghi MI; Canevari S
    Cancer Res; 1996 Dec; 56(23):5443-9. PubMed ID: 8968099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of an optimised gene transfer protocol for human primary T lymphocytes according to clinical requirements.
    Ayuk F; Li Z; Kühlcke K; Lindemann C; Schade U; Eckert HG; Zander A; Fehse B
    Gene Ther; 1999 Oct; 6(10):1788-92. PubMed ID: 10516731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
    Chen HW; Liao CH; Ying C; Chang CJ; Lin CM
    Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro stimulation and expansion of human tumour-reactive CD8+ cytotoxic T lymphocytes by anti-CD3/CD28/CD137 magnetic beads.
    Teschner D; Wenzel G; Distler E; Schnürer E; Theobald M; Neurauter AA; Schjetne K; Herr W
    Scand J Immunol; 2011 Aug; 74(2):155-64. PubMed ID: 21517928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor activity and some immunological properties of gammadelta T-cells from patients with gastrointestinal carcinomas.
    Murayama M; Tanaka Y; Yagi J; Uchiyama T; Ogawa K
    Anticancer Res; 2008; 28(5B):2921-31. PubMed ID: 19031935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Repeated passive immunotherapy delays AIDS progression].
    Paris KA
    Fortschr Med; 1995 May; 113(14):13. PubMed ID: 7607586
    [No Abstract]   [Full Text] [Related]  

  • 10. Defective clonogenic potential of CD8+ T lymphocytes in patients with AIDS. Expansion in vivo of a nonclonogenic CD3+CD8+DR+CD25- T cell population.
    Pantaleo G; Koenig S; Baseler M; Lane HC; Fauci AS
    J Immunol; 1990 Mar; 144(5):1696-704. PubMed ID: 2137842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of lentiviral vector transduction into peripheral blood mononuclear cells in combination with the fibronectin fragment CH-296 stimulation.
    Chono H; Goto Y; Yamakawa S; Tanaka S; Tosaka Y; Nukaya I; Mineno J
    J Biochem; 2011 Mar; 149(3):285-92. PubMed ID: 21106541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depletion of pro-inflammatory CD161(+) double negative (CD3(+)CD4(-)CD8(-)) T cells in AIDS patients is ameliorated by expansion of the γδ T cell population.
    Singleterry WL; Henderson H; Cruse JM
    Exp Mol Pathol; 2012 Feb; 92(1):155-9. PubMed ID: 22100877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cord blood T cells cultured with IL-7 in addition to IL-2 exhibit a higher degree of polyfunctionality and superior proliferation potential.
    Berglund S; Gertow J; Magalhaes I; Mattsson J; Uhlin M
    J Immunother; 2013 Oct; 36(8):432-41. PubMed ID: 23994891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of T-cell response to CD3 plus CD28 monoclonal antibodies in HIV-1 infected subjects treated with highly active antiretroviral therapy.
    Carlesimo M; Bernardi ML; Mattiacci G; Pierdominici M; Ferrara R; Donnanno S; Alario C; Aiuti F
    J Biol Regul Homeost Agents; 2000; 14(1):38-40. PubMed ID: 10763891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adoptively transferred anti-CD3-activated T cells for human tumor immunotherapy.
    Gold JE
    J Clin Oncol; 1993 Sep; 11(9):1836-7. PubMed ID: 8355052
    [No Abstract]   [Full Text] [Related]  

  • 16. Targeting acute allograft rejection by immunotherapy with ex vivo-expanded natural CD4+ CD25+ regulatory T cells.
    Xia G; He J; Zhang Z; Leventhal JR
    Transplantation; 2006 Dec; 82(12):1749-55. PubMed ID: 17198271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid induction of cytolytic T cells via CD28 stimulation for cellular immunotherapy.
    Blum S; Milesi R; Tratkiewicz J; Olive D; Gallati H; Cerottini JC; von Fliedner V
    Ther Immunol; 1994 Jun; 1(3):143-52. PubMed ID: 7584490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adoptive T-cell immunotherapy of cancer.
    Li Q; Chang AE
    Cytokines Cell Mol Ther; 1999 Jun; 5(2):105-17. PubMed ID: 10515683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of autologous tumor-specific T cells for adoptive transfer based on vaccination, in vitro restimulation and CD3/CD28 dynabead-induced T cell expansion.
    Brimnes MK; Gang AO; Donia M; Thor Straten P; Svane IM; Hadrup SR
    Cancer Immunol Immunother; 2012 Aug; 61(8):1221-31. PubMed ID: 22237888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic T cells reactive to an immunodominant leukemia-associated antigen can be specifically primed and expanded by combining a specific priming step with nonspecific large-scale expansion.
    Ghosh A; Wolenski M; Klein C; Welte K; Blazar BR; Sauer MG
    J Immunother; 2008; 31(2):121-31. PubMed ID: 18481382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.